Cardiotoxicity of immune checkpoint inhibitors: A meta-analysis of randomized clinical trials

被引：0
|
作者：
Agostinetto, E. [1 ]
Eiger, D. [1 ]
Lambertini, M. [2 ]
Ceppi, M. [3 ]
Bruzzone, M. [3 ]
Ponde, N. F. [4 ]
Plummer, C. [5 ]
Awada, A. H. [6 ]
Piccart, M. [6 ]
de Azambuja, E. [1 ]
机构：
[1] Inst Jules Bordet, Acad Trials Promoting Team, Brussels, Belgium
[2] IRCCS Osped Policlin San Martino, Dept Med Oncol, Genoa, Italy
[3] IRCCS Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy
[4] AC Camargo Canc Ctr, Clin Oncol, Sao Paulo, Brazil
[5] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[6] Inst Jules Bordet, Oncol Dept, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41P
引用
收藏
页码：S1432 / S1432
页数：1
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors in clinical trials
    Elad Sharon
    Howard Streicher
    Priscila Goncalves
    Helen XChen
    Chinese Journal of Cancer, 2014, 33 (09) : 434 - 444
  • [22] A meta-analysis of immune-related adverse events (irAE) of immune checkpoint inhibitors (ICI) from cancer clinical trials
    El Osta, B.
    Hu, F.
    Sadek, R.
    Chintalapally, R.
    Tang, S-C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Efficacy and safety of immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC): A systematic review and meta-analysis of randomized clinical trials (RCTs).
    Jacome, Alexandre A.
    Guimaraes De Castro, Ana Carolina
    Solar Vasconcelos, Joao Paulo
    Cruz Rangel Silva, Maria Helena
    Oliveira Lessa, Marco Antonio
    de Moraes, Eduardo Dias
    Andrade, Aline Chaves
    Figueiredo Ferreira, Barbara Sodre
    Lima, Frederico M. T.
    Bulcao, Marcela Lima
    Ferreira, Artur Rodrigues
    Fogacci De Farias, Joao Paulo
    Prolla, Gabriel
    Garicochea, Bernardo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] The Effect of Sex on the Therapeutic Efficiency of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
    Zhong, Xingyu
    Sun, Jianxuan
    Zeng, Na
    Xiong, Yifan
    An, Ye
    Wang, Shaogang
    Xia, Qidong
    CANCERS, 2024, 16 (02)
  • [25] Cardiotoxicity as an adverse effect of immunomodulatory drugs and proteasome inhibitors in multiple myeloma: A network meta-analysis of randomized clinical trials
    Das, Avash
    Dasgupta, Subhajit
    Gong, Yan
    Shah, Urvi A.
    Fradley, Michael G.
    Cheng, Richard K.
    Roy, Bhaskar
    Guha, Avirup
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) : 233 - 242
  • [26] The Cardiotoxicity Risk of Immune Checkpoint Inhibitors Compared with Chemotherapy: A Systematic Review and Meta-analysis of Observational Studies
    Zheng, Yingying
    Liu, Zishen
    Chen, Dong
    Zhang, Jingzhi
    Yuan, Mengqi
    Zhang, Yutong
    Liu, Shiyu
    Zhang, Ganlin
    Yang, Guowang
    CARDIOVASCULAR TOXICOLOGY, 2025,
  • [27] Risk Factors for Cardiotoxicity in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review With Meta-Analysis
    Huang, Chin-Hsuan
    Abdul-Lattif, Eahab
    Azmat, Muneeba
    Chang, Yu
    Lin, Yu Shiuan
    Md, Michele Nanna
    Chi, Kuan Yu
    CIRCULATION, 2022, 146
  • [28] Meta-analysis: cutaneous irAEs with immune checkpoint inhibitors
    Reactions Weekly, 2021, 1864 (1) : 10 - 10
  • [29] Immune checkpoint inhibitors in adrenocortical carcinoma: A meta-analysis
    Ababneh, O.
    Al-Horani, S.
    Ghazou, A.
    Alawajneh, M.
    Shehadeh, B.
    Kadoumi, O.
    Mohammad, S. Alhaj
    Bani-Hani, A.
    Alrabadi, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S546 - S546
  • [30] CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE
    Frascaro, F.
    Pavasini, R.
    Marchini, F.
    Bianchi, N.
    Zanarelli, L.
    Sanguettoli, F.
    Meossi, S.
    Guardigli, G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D211 - D211
12345